合成路线1
该中间体在本合成路线中的序号:
(II) The condensation of 4-fluorophenol (I) with 1,2-dibromoethane (II) in basic medium gives 2-(4-fluorophenyl)ethyl bromide (III), which by reaction with N-benzoyl-2-hydroxyglycine (IV) in methanesulfonic acid yields N-benzoyl-2-[2-(2-bromoethoxy)-5-fluorophenyl]glycine (V). The cyclization of (V) with acetic anhydride and triethylamine at 50 C affords 6-fluoro-2'-phenylspiro[2,3-dihydro-4H-1-benzopyran-4,4'-oxazolidine]-5'-one (VI), which is hydrolyzed with refluxing formic acid-HCl giving the amino acid (VII). The esterification of (VII) with SOCl2 and methanol in the usual way yields the methyl ester (VIII), which is submitted to optical resolution by selective hydrolysis with alpha-chymotrypsine affording methyl 4(S)-amino-6-fluoro-2,3-dihydro-4H-1-benzopyrano-4-carboxylate (IX). Finally, this compound is converted into sorbinil by cyclization with sodium cyanate in acetic acid at room temperature.
【1】
Dirlam, N.L.; Moore, B.S.; Urban, F.J.; Novel synthesis of the aldose reductase inhibitor sorbinil via amidoalkylation, intramolecular oxazolidin-5-one alkylation, and chymotrypsin resolution. J Org Chem 1987, 52, 16, 3587-91.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19369 |
2-iodopropane
|
75-30-9 |
C3H7I |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
20830 |
1-(2-bromoethoxy)-4-fluorobenzene; 2-bromoethyl 4-fluorophenyl ether
|
332-48-9 |
C8H8BrFO |
详情 | 详情
|
(IV) |
20606 |
2-(benzoylamino)-2-hydroxyacetic acid
|
16555-77-4 |
C9H9NO4 |
详情 | 详情
|
(V) |
20832 |
2-(benzoylamino)-2-[2-(2-bromoethoxy)-5-fluorophenyl]acetic acid
|
|
C17H15BrFNO4 |
详情 |
详情
|
(VI) |
20833 |
6-Fluoro-2'-phenyl-3,4,4',5'-tetrahydro-2H-spiro[1-benzopyran-4,4'-oxazol]-5'-one
|
|
C17H12FNO3 |
详情 |
详情
|
(VII) |
20834 |
4-amino-6-fluoro-4-chromanecarboxylic acid
|
|
C10H10FNO3 |
详情 |
详情
|
(VIII) |
20835 |
methyl 4-amino-6-fluoro-4-chromanecarboxylate
|
|
C11H12FNO3 |
详情 |
详情
|
(IX) |
20836 |
[(4S)-4-amino-6-fluoro-3,4-dihydro-2H-chromen-4-yl]methyl formate
|
|
C11H12FNO3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) A new synthesis of dazoxiben has been described:
The condensation of methyl 4-hydroxybenzoate (I) with 1,2-dibromoethane (II) by means of NaOH gives methyl 4-(2-bromoethoxy)benzoate (III), which is hydrolyzed with H2SO4 to the corresponding free acid (IV). Finally, this compound is condensed with imidazole (V) in refluxing butanol.
【1】
Palei, R.M.; Kochergin, P.M.; Balandina, L.V.; Govorukhina, E.I.; Persanova, L.V.; Frolova, M.A.; Kravchenko, A.N.; Kharitonova, A.E.; A simplified synthesis of dazoxibene. Khim Farm Zh 1995, 29, 2, 56.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10251 |
methyl 4-hydroxybenzoate; Methyl p-hydroxybenzoate
|
99-76-3 |
C8H8O3 |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
10253 |
methyl 4-(2-bromoethoxy)benzoate
|
56850-91-0 |
C10H11BrO3 |
详情 | 详情
|
(IV) |
10254 |
4-(2-bromoethoxy)benzoic acid
|
51616-09-2 |
C9H9BrO3 |
详情 | 详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) By condensation of 4-(4-fluorobenzoyl)piperidine (IX) with 6-(2-bromo ethyl)-7-methyl-2,3-dihydro-5H-thiazolo[2,3-a]pyrimidin-5-one (IV) by means of Na2CO3 in refluxing 4-methyl-2-pentanone.
The starting products are obtained as follows: The cyclization of 4-hydroxy-5-(2-hydroxyethyl)-6-methyl-2-mercaptopyrimidine (I) with 1,2-dibromo ethane (II) by means of K2CO3 in hot dimethylacetamide gives 2,3-dihydro-6-(2-hydroxyethyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one (II), which by reaction with HBr in refluxing acetic acid is converted to the corresponding 6-(2-bromoethyl) derivative (IV).
The Grignard reaction of 4-bromofluorobenzene (V) with N benzyl-4 cyanopiperidine (VI) by means of Mg in dimethoxyethane gives 4-(4-fluorobenzoyl)-N-benzylpiperidine (VII), which is treated with ethyl chlorocarbo-nate in refluxing toluene to afford ethyl 4-(4-fluorobenzoyl)piperidine-1-carboxylate (VIII). Finally, this compound is treated with HBr in refluxing 48% HBr to give (IX).
【1】
Kennis, L.; Mertens, J.C. (Janssen Pharmaceutica NV); Bicyclic pyrimidin-5-one derivatives. DD 215553; EP 0070053; US 4443451 .
|
【2】
Serradell, M.N.; Castaner, J.; Setoperone. Drugs Fut 1985, 10, 1, 40.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29009 |
5-(2-hydroxyethyl)-6-methyl-2-sulfanyl-4-pyrimidinol
|
|
C7H10N2O2S |
详情 |
详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
29010 |
6-(2-hydroxyethyl)-7-methyl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one
|
|
C9H12N2O2S |
详情 |
详情
|
(IV) |
29011 |
6-(2-bromoethyl)-7-methyl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one
|
|
C9H11BrN2OS |
详情 |
详情
|
(V) |
29012 |
1-bromo-4-fluorobenzene
|
460-00-4 |
C6H4BrF |
详情 | 详情
|
(VI) |
29013 |
1-benzyl-4-piperidinecarbonitrile
|
|
C13H16N2 |
详情 |
详情
|
(VII) |
29014 |
(1-benzyl-4-piperidinyl)(4-fluorophenyl)methanone
|
|
C19H20FNO |
详情 |
详情
|
(VIII) |
29015 |
ethyl 4-(4-fluorobenzoyl)-1-piperidinecarboxylate
|
|
C15H18FNO3 |
详情 |
详情
|
(IX) |
21497 |
(4-Fluorophenyl)(4-piperidinyl)methanone; 4-(4-Fluorobenzoyl)piperidine; 4-(p-Fluorobenzoyl)piperidine
|
56346-57-7 |
C12H14FNO |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(X) The reaction of 4-oxopiperidine-1-carboxylic acid ethyl ester (I) with CHCl3, benzyl triethylammonium chloride and NaOH in THF/water gives the spirooxirane (II), which is treated with aniline (III) and NaOH to yield the anilide (IV). The methylation of the amide nitrogen by means of NaH and CH3I in THF affords the methylated anilide (V). The reaction of (V) with KOH in refluxing isopropanol causes elimination of its ethoxycarbonyl group, providing compound (VI), which is reduced with lithium triethylborohydride in THF to give 4-(hydroxymethyl)-4-(phenylamino)piperidine (VII). The condensation of (VII) with tetrazolone derivative (VIII) by means of KI in refluxing acetonitrile (or propionitrile) yields the adduct (XI), which is methylated with NaH and CH3I in THF to afford the methoxy derivative (XII). Finally, this compound is acylated with propionyl chloride (XIII) in chloroform to provide the target compound.
The intermediate tetrazolone derivative (VIII) has been obtained by reaction of 1-ethyl-4,5-dihydro-1H-tetrazol-5-one (IX) with 1,2-dibromoethane (X) by means of TEA in acetonitrile.
【1】
Killgore, J.K.; Jacob, M. (Mallinckrodt Medical Inc.); New methods for the syntheses of alfentanil, sufentanil and remifentanil. WO 0140184 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13486 |
Ethyl 4-oxo-1-piperidinecarboxylate; N-Carbethoxy-4-piperidone
|
29976-53-2 |
C8H13NO3 |
详情 | 详情
|
(II) |
49678 |
ethyl 2,2-dichloro-1-oxa-6-azaspiro[2.5]octane-6-carboxylate
|
|
C9H13Cl2NO3 |
详情 |
详情
|
(III) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(IV) |
49679 |
ethyl 4-anilino-4-(anilinocarbonyl)-1-piperidinecarboxylate
|
|
C21H25N3O3 |
详情 |
详情
|
(V) |
49680 |
ethyl 4-anilino-4-[(methylanilino)carbonyl]-1-piperidinecarboxylate
|
|
C22H27N3O3 |
详情 |
详情
|
(VI) |
49681 |
4-anilino-N-methyl-N-phenyl-4-piperidinecarboxamide
|
|
C19H23N3O |
详情 |
详情
|
(VII) |
49682 |
(4-anilino-4-piperidinyl)methanol
|
|
C12H18N2O |
详情 |
详情
|
(VIII) |
14721 |
1-(2-bromoethyl)-4-ethyl-1,4-dihydro-5H-1,2,3,4-tetraazol-5-one
|
|
C5H9BrN4O |
详情 |
详情
|
(IX) |
32218 |
1-ethyl-1,4-dihydro-5H-1,2,3,4-tetraazol-5-one
|
69048-98-2 |
C3H6N4O |
详情 | 详情
|
(X) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(XI) |
49683 |
1-[2-[4-anilino-4-(hydroxymethyl)-1-piperidinyl]ethyl]-4-ethyl-1,4-dihydro-5H-1,2,3,4-tetraazol-5-one
|
|
C17H26N6O2 |
详情 |
详情
|
(XII) |
49684 |
1-[2-[4-anilino-4-(methoxymethyl)-1-piperidinyl]ethyl]-4-ethyl-1,4-dihydro-5H-1,2,3,4-tetraazol-5-one
|
|
C18H28N6O2 |
详情 |
详情
|
(XIII) |
15967 |
propanoyl chloride; propionyl chloride
|
79-03-8 |
C3H5ClO |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(XIII) Treatment of alpha-chlorophenylacetyl chloride (VIII) with methylamine provided the corresponding chloro amide (IX), which was subsequently condensed with 2-aminobenzyl alcohol (X) to afford amino alcohol (XI). Cyclization of (XI) in the presence of AlCl3 led to the dibenzoazepine (XII). This was converted to the tetracyclic compound (XIV) by reaction with dibromoethane (XIII) in the presence of Na2CO3. Reduction of the amide carbonyl group of (XIV) by means of LiAlH4 furnished the title compound. In a related strategy, amide (XII) was initially reduced to diamine (VI) by using LiAlH4. Subsequent condensation of (VI) with dibromoethane (XIII) led to the target tetracyclic derivative
【1】
Haider, A.; Bollinger, H.; Fischer, A. (Sochinaz SA); Process for the preparation of a tetracyclic compound and application of this process for the preparation of 1,2,3,4,10,14b-hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin. FR 2647114 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
62397 |
6,11-dihydro-5H-dibenzo[b,e]azepin-6-yl-N-methylmethanamine; N-(6,11-dihydro-5H-dibenzo[b,e]azepin-6-ylmethyl)-N-methylamine
|
|
C16H18N2 |
详情 |
详情
|
(VIII) |
62399 |
2-chloro-2-phenylacetyl chloride
|
|
C8H6Cl2O |
详情 |
详情
|
(IX) |
62400 |
2-chloro-N-methyl-2-phenylacetamide
|
|
C9H10ClNO |
详情 |
详情
|
(X) |
18619 |
(2-aminophenyl)methanol; 2-Amino-benzenemethanol;2-Hydroxymethyl aniline;2-aminobenzyl alcohol;o-Aminobenzyl 2-aminobenzylalcohol;alcohol; 2-aminobenzenemethanol; 2-aminobenzyl alcohol |
5344-90-1 |
C7H9NO |
详情 | 详情
|
(XI) |
62401 |
2-[2-(hydroxymethyl)anilino]-N-methyl-2-phenylacetamide
|
|
C16H18N2O2 |
详情 |
详情
|
(XII) |
62402 |
N-methyl-6,11-dihydro-5H-dibenzo[b,e]azepine-6-carboxamide
|
|
C16H16N2O |
详情 |
详情
|
(XIII) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(XIV) |
62403 |
2-methyl-3,4,10,14b-tetrahydrodibenzo[c,f]pyrazino[1,2-a]azepin-1(2H)-one
|
|
C18H18N2O |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(XIII) The key intermediate (XXI) was also prepared by several related procedures. Chlorination of aminoalcohol (XVI) gave chloro amine (XXIV), which was condensed with 2-aminobenzyl alcohol (X) to afford diamine (XXV). Then, alkylation of diamine (XXV) with dibromoethane (XIII) in hot pyridine gave rise to the target piperazine (XXI). Alternatively, diamine (XXV) was condensed with ethyl chloroacetate or with diethyl oxalate to produce the mono- or dioxopiperazines (XXVII) and (XXVI), respectively, which were then reduced to (XXI) by means of LiAlH4. Cyclization of alcohol (XXI) to the title compound was achieved by treatment with concentrated sulfuric acid
【1】
Olivié, J.; Synthesis for the preparation of tetracyclic cpds.. US 4217452 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16601 |
ethyl chloroacetate; ethyl 2-chloroacetate
|
105-39-5 |
C4H7ClO2 |
详情 | 详情
|
(X) |
18619 |
(2-aminophenyl)methanol; 2-Amino-benzenemethanol;2-Hydroxymethyl aniline;2-aminobenzyl alcohol;o-Aminobenzyl 2-aminobenzylalcohol;alcohol; 2-aminobenzenemethanol; 2-aminobenzyl alcohol |
5344-90-1 |
C7H9NO |
详情 | 详情
|
(XIII) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(XVI) |
62404 |
2-(methylamino)-1-phenyl-1-ethanol
|
|
C9H13NO |
详情 |
详情
|
(XXI) |
62407 |
[2-(4-methyl-2-phenyl-1-piperazinyl)phenyl]methanol
|
|
C18H22N2O |
详情 |
详情
|
(XXIV) |
62410 |
|
|
C10H16ClN |
详情 |
详情
|
(XXV) |
62411 |
(2-{[2-(methylamino)-1-phenylethyl]amino}phenyl)methanol
|
|
C16H20N2O |
详情 |
详情
|
(XXVI) |
62413 |
4-[2-(hydroxymethyl)phenyl]-1-methyl-5-phenyl-2,3-piperazinedione
|
|
C18H18N2O3 |
详情 |
详情
|
(XXVII) |
62412 |
1-[2-(hydroxymethyl)phenyl]-4-methyl-6-phenyl-2-piperazinone
|
|
C18H20N2O2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The alkylation of succinimide (I) with 1,2-dibromoethane (II) by means of K2CO3 in refluxing butanone gives N-(2-bromoethyl)succinimide (III), which is condensed with 4-hydroxythiophenol (IV) by means of K2CO3 in refluxing ethanol to afford 4-hydroxyphenyl 2-succinimidoethyl sulfide (V). Finally, this compound is esterified with 4-guanidinobenzoyl chloride in pyridine, and treated with methanesulfonic acid in methanol.
【1】
Hishinuma, I.; Kawashima, H.; Kawata, T.; Miyamoto, K.; Miyazawa, S.; Nagakawa, J.; Nagaoka, J.; Nagaoka, N.; Shimomura, N.; Souda, S.; Ueda, N.; Wakabayashi, T.; Yamanaka, T. (Eisai Co., Ltd.); Guanidinobenzoic ester deriv., a process for preparing same and pharmaceutical compsns. containing same. EP 0229370; JP 1987155253; JP 1994298730; US 4801603; US 5075335 . |
【2】
Prous, J.; Castaner, J.; E-3123. Drugs Fut 1988, 13, 7, 613.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22543 |
2,5-pyrrolidinedione
|
123-56-8 |
C4H5NO2 |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
22545 |
1-(2-bromoethyl)-2,5-pyrrolidinedione
|
|
C6H8BrNO2 |
详情 |
详情
|
(IV) |
22546 |
4-sulfanylphenol
|
637-89-8 |
C6H6OS |
详情 | 详情
|
(V) |
22547 |
1-[2-[(4-hydroxyphenyl)sulfanyl]ethyl]-2,5-pyrrolidinedione
|
|
C12H13NO3S |
详情 |
详情
|
(VI) |
22548 |
4-[[amino(imino)methyl]amino]benzoyl chloride
|
|
C8H8ClN3O |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(XXXII) b) The intermediate 7(S)-(tert-Butoxycarbonylamino)-5-azaspiro[2.4]heptane (VII) can also be obtained as follows:
1) The cyclopropanation of ethyl acetoacetate (XXXI) with 1,2-dibromoethane (XXXII) by means of K2CO3 in DMF gives 1-acetylcyclopropane-1-carboxylic acid ethyl ester (XXXIII), which is brominated with Br2 in ethanol yielding the bromoacetyl derivative (XXXIV). The cyclization of (XXXI) with (R)-alpha-methylbenzylamine (XIII) by means of triethylamine affords 5-[1(R)-phenylethyl]-5-azaspiro[2.4]heptane-4,7-dione (XXXV), which by reaction with hydroxylamine is converted into the monooxime (XXXVI). The reduction of (XXXVI) with H2 over RaNi in methanol affords 7-amino-5-[1(R)-phenylethyl]-5-azaspiro[2.4]heptan-4-one as a diastereomeric mixture (XXXVII) + (XXXVIII), which is separated by column chromatography. The reduction of the (7S)-isomer (XXXVIII) with LiAlH4 in THF gives 7(S)-amino-5-[1(R)-phenylethyl]-5-azaspiro[2.4]heptane (XXXIX), which is protected in the usual way to the tert-butoxycarbonyl derivative (XL). Finally, this compound is debenzylated to (VII) by hydrogenation with H2 over Pd/C in ethanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXXIX)) |
15177 |
(7S)-5-[(1R)-1-phenylethyl]-5-azaspiro[2.4]heptan-7-amine; (7S)-5-[(1R)-1-phenylethyl]-5-azaspiro[2.4]hept-7-ylamine
|
|
C14H20N2 |
详情 |
详情
|
(VII) |
15131 |
N-[(7S)-5-azaspiro[2.4]hept-7-yl]carbamic acid tert-butyl ester |
127199-45-5 |
C11H20N2O2 |
详情 | 详情
|
(XIII) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
(XXXI) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
(XXXII) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(XXXIII) |
15171 |
ethyl 1-acetylcyclopropanecarboxylate
|
|
C8H12O3 |
详情 |
详情
|
(XXXIV) |
15172 |
ethyl 1-(2-bromoacetyl)cyclopropanecarboxylate
|
|
C8H11BrO3 |
详情 |
详情
|
(XXXV) |
15173 |
5-[(1R)-1-phenylethyl]-5-azaspiro[2.4]heptane-4,7-dione
|
|
C14H15NO2 |
详情 |
详情
|
(XXXVI) |
15174 |
5-[(1R)-1-phenylethyl]-5-azaspiro[2.4]heptane-4,7-dione 7-oxime
|
|
C14H16N2O2 |
详情 |
详情
|
(XXXVII) |
15175 |
(7R)-7-amino-5-[(1R)-1-phenylethyl]-5-azaspiro[2.4]heptan-4-one
|
|
C14H18N2O |
详情 |
详情
|
(XXXVIII) |
15176 |
(7S)-7-amino-5-[(1R)-1-phenylethyl]-5-azaspiro[2.4]heptan-4-one
|
|
C14H18N2O |
详情 |
详情
|
(XL) |
15178 |
N-[(7S)-5-[(1R)-1-phenylethyl]-5-azaspiro[2.4]hept-7-yl]carbamic acid
|
|
C15H20N2O2 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(V) An efficient synthesis of 7(S)-(tert-butoxycarbonylamino)-5-azaspiro[2.4]heptane (XI), a key intermediate in the synthesis of DU-6859a, via an asymmetric microbial reduction has been described:
The reaction of N-benzylglycine (I) with tert-butoxycarbonyl anhydride gives N-benzyl-N-(tert-butoxycarbonyl)glycine (II), which is condensed with the potassium salt of ethyl hydrogen malonate (III) by means of carbonyldiimidazole (CDI) in THF yielding 4-[N-benzyl-N-(tert-butoxycarbonyl)amino]-3-oxobutyric acid ethyl ester (IV). The cyclopropanation of (IV) with 1,2-dibromoethane (V) by means of K2CO3 in refluxing acetone affords the cyclopropane derivative (VI), which is cyclized by means of trifluoroacetic acid in dichloromethane to give 5-benzyl-5-azaspiro[2.4]heptane-4,7-dione (VII). The enantioselective microbial reduction of (VII) by means of Phaeocreopsis sp. JCM 1880 in a complex medium containing glucose and polypeptone yields 5-benzyl-7(R)-hydroxy-5-azaspiro[2.4]heptan-4-one (VIII), which by reaction with triphenylphosphine, diethyl azodicarboxylate and diphenylphosphoryl azide (DPPA) followed by reduction with LiAlH4, is converted into 7(S)-amino-5-benzyl-5-azaspiro[2.4]heptane (IX). The protection of (IX) with tert-butoxycarbonyl anhydride as usual gives the protected amine (X), which is finally debenzylated by hydrogenation with H2 over Pd/C in ethanol affording the desired 7(S)-(tert-butoxycarbonylamino)-5-azaspiro[2.4]heptane (XI).
【1】
Yukimoto, Y.; Imura, A.; Satoh, K.; Kanai, K.; Miyadera, A.; An efficient synthesis of a key intermediate of DU-6859a via asymmetric microbial reduction. Chem Pharm Bull 1998, 46, 4, 587.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27895 |
N-(benzylamino)acetic acid; N-Benzylglycine; 2-(benzylamino)acetic acid
|
17136-36-6 |
C9H11NO2 |
详情 | 详情
|
(II) |
27846 |
2-[benzyl(tert-butoxycarbonyl)amino]acetic acid
|
|
C14H19NO4 |
详情 |
详情
|
(III) |
14338 |
potassium 3-ethoxy-3-oxopropanoate
|
6148-64-7 |
C5H7KO4 |
详情 | 详情
|
(IV) |
27896 |
ethyl 4-[benzyl(tert-butoxycarbonyl)amino]-3-oxobutanoate
|
|
C18H25NO5 |
详情 |
详情
|
(V) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(VI) |
27897 |
ethyl 1-[2-[benzyl(tert-butoxycarbonyl)amino]acetyl]cyclopropanecarboxylate
|
|
C20H27NO5 |
详情 |
详情
|
(VII) |
27898 |
5-benzyl-5-azaspiro[2.4]heptane-4,7-dione
|
|
C13H13NO2 |
详情 |
详情
|
(VIII) |
27899 |
(7R)-5-benzyl-7-hydroxy-5-azaspiro[2.4]heptan-4-one
|
|
C13H15NO2 |
详情 |
详情
|
(IX) |
27900 |
(7S)-5-benzyl-5-azaspiro[2.4]hept-7-ylamine
|
|
C13H18N2 |
详情 |
详情
|
(X) |
27901 |
tert-butyl (7S)-5-benzyl-5-azaspiro[2.4]hept-7-ylcarbamate
|
|
C18H26N2O2 |
详情 |
详情
|
(XI) |
15193 |
tert-butyl N-[(7S)-5-azaspiro[2.4]hept-7-yl]carbamate
|
|
C11H20N2O2 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(XXII) The bromination of 1-acetyl-5-propionylindoline (I) with pyrrolidone hydrotribromide (PTBr) and sulfuric acid in THF gives the alpha-bromo derivative (II), which is reduced with triethylsilane in TFA yielding the 2-bromopropyl compound (III). Nitration of (III) with HNO3 in HOAc affords the 7-nitroindoline (IV), which is reduced to the corresponding amine derivative (V) with H2 over PtO2 in ethanol. The reaction of amine (V) with NaNO2/HCl, followed by treatment with CuCN, provides 1-acetyl-5-(2-bromopropyl)indoline-7-carbonitrile (VI), which is treated with NaN3 in hot ethylene glycol monomethyl ether/water to yield the 2-azidopropyl derivative (VII). Reduction of (VII) with H2 over Pd/BaSO4 in ethanol affords the expected 2-aminopropyl compound (VIII), which is condensed with 2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl bromide (IX) by means of NaHCO3 in ethanol to provide the secondary amine (X).
The intermediate 2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl bromide (IX) has been obtained as follows: Alkylation of 2-methoxyphenol (XVIII) with 2,2,2-trifluoroethyl iodide (XIX) by means of K2CO3 in hot DMF gives 1-methoxy-2-(2,2,2-trifluoroethoxy)benzene (XX), which is demethylated by means of BBr3 in dichloromethane to yield the corresponding phenol (XXI). Finally, this compound is alkylated with 1,2-dibromoethane (XXII) and NaOH in water at 120 C (1,2).
【1】
Sorbera, L.A.; Castaner, J.; Silvestre, J.S.; KMD-3213. Drugs Fut 2001, 26, 6, 553.
|
【2】
Kitazawa, M.; Ban, M.; Okazaki, K.; Ozawa, M.; Yazaki, T.; Yamagishi, R. (Kissei Pharmaceutical Co., Ltd.); Indoline cpds. for the treatment of dysuria. EP 0600675; JP 1994220015; US 5387603 .
|
【3】
Kitazawa, M.; Ozawa, M.; Okazaki, K.; Yamagishi, R.; Yazaki, T.; Saka, M. (Kissei Pharmaceutical Co., Ltd.); Indole derivs.. JP 1995330726 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47548 |
1-(1-acetyl-2,3-dihydro-1H-indol-5-yl)-1-propanone
|
|
C13H15NO2 |
详情 |
详情
|
(II) |
47549 |
1-(1-acetyl-2,3-dihydro-1H-indol-5-yl)-2-bromo-1-propanone
|
|
C13H14BrNO2 |
详情 |
详情
|
(III) |
47550 |
1-[5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C13H16BrNO |
详情 |
详情
|
(IV) |
47551 |
1-[5-(2-bromopropyl)-7-nitro-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C13H15BrN2O3 |
详情 |
详情
|
(V) |
47552 |
1-[7-amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C13H17BrN2O |
详情 |
详情
|
(VI) |
47553 |
1-acetyl-5-(2-bromopropyl)-7-indolinecarbonitrile
|
|
C14H15BrN2O |
详情 |
详情
|
(VII) |
47554 |
1-acetyl-5-(2-azidopropyl)-7-indolinecarbonitrile
|
|
C14H15N5O |
详情 |
详情
|
(VIII) |
47555 |
1-acetyl-5-(2-aminopropyl)-7-indolinecarbonitrile
|
|
C14H17N3O |
详情 |
详情
|
(IX) |
47556 |
1-(2-bromoethoxy)-2-(2,2,2-trifluoroethoxy)benzene; 2-(2-bromoethoxy)phenyl 2,2,2-trifluoroethyl ether
|
|
C10H10BrF3O2 |
详情 |
详情
|
(X) |
47557 |
1-acetyl-5-[2-([2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino)propyl]-7-indolinecarbonitrile
|
|
C24H26F3N3O3 |
详情 |
详情
|
(XVIII) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(XIX) |
18806 |
1,1,1-trifluoro-2-iodoethane
|
353-83-3 |
C2H2F3I |
详情 | 详情
|
(XX) |
47558 |
1-methoxy-2-(2,2,2-trifluoroethoxy)benzene; 2-methoxyphenyl 2,2,2-trifluoroethyl ether
|
|
C9H9F3O2 |
详情 |
详情
|
(XXI) |
47559 |
2-(2,2,2-trifluoroethoxy)phenol
|
|
C8H7F3O2 |
详情 |
详情
|
(XXII) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) Alkylation of phenol (I) with 1,2-dibromoethane (II) in the presence of K2CO3 in DMF yielded bromoethyl ether (III), which was further, condensed with amine (IV) to afford tertiary amine (V). The nitro group of (V) was then reduced by either catalytic hydrogenation in the presence of Pd/C or by treatment with SnCl2 in aqueous HCl, and the resulting aniline (VI) was condensed with methanesulfonyl chloride in pyridine to give sulfonamide (VII). Finally, acid hydrolysis of the acetamido group provided the title compound.
【1】
Kim, D.-I.; Kim, H.Y.; Kwon, L.S.; Park, S.D.; Jeon, G.H.; Jung, K.Y.; Min, J.K.; Nam, W.H.; Lee, K.; Chung, Y.S.; Tanabe, S.; Kozono, T.; Synthesis and biological activity of KCB-328 and its analogues: Novel class III antiarrhythmic agents with little reverse frequency dependence. Bioorg Med Chem Lett 1999, 9, 1, 85. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19881 |
N-(2-hydroxy-5-nitrophenyl)acetamide
|
|
C8H8N2O4 |
详情 |
详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
18938 |
2-(3,4-dimethoxyphenyl)-N-methyl-1-ethanamine; N-(3,4-dimethoxyphenethyl)-N-methylamine
|
3490-06-0 |
C11H17NO2 |
详情 | 详情
|
(III) |
19883 |
N-[2-(2-bromoethoxy)-5-nitrophenyl]acetamide
|
|
C10H11BrN2O4 |
详情 |
详情
|
(V) |
19885 |
N-(2-[2-[(3,4-dimethoxyphenethyl)(methyl)amino]ethoxy]-5-nitrophenyl)acetamide
|
|
C21H27N3O6 |
详情 |
详情
|
(VI) |
19886 |
N-(5-amino-2-[2-[(3,4-dimethoxyphenethyl)(methyl)amino]ethoxy]phenyl)acetamide
|
|
C21H29N3O4 |
详情 |
详情
|
(VII) |
19887 |
N-[2-[2-[(3,4-dimethoxyphenethyl)(methyl)amino]ethoxy]-5-[(methylsulfonyl)amino]phenyl]acetamide
|
|
C22H31N3O6S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
Reaction of 4-amino-5-chloro-2-methoxybenzoic acid (I) with 1,2-dibromoethane in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene afforded bromoethyl ester (II). This was then condensed with a mixture of cis and trans 3,5-dimethylpiperidines (III), and the resulting mixture of amines was finally separated by column chromatogaphy to provide the target cis compound.
【1】
Sicsic, S.; Soulier, J.-L.; Yang, D.; et al.; New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors. J Med Chem 1997, 40, 4, 608.
|
【2】
Langlois, M.; Guzzi, U.; Cecchi, R.; Croci, T. (Midy SpA); Esters of 4-amino-5-chloro-2-methoxybenzoic acid, process for their preparation and pharmaceutical compsns. containing them. EP 0683161 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(I) |
12419 |
4-Amino-5-chloro-2-methoxybenzoic acid
|
7206-70-4 |
C8H8ClNO3 |
详情 | 详情
|
(II) |
26533 |
2-bromoethyl 4-amino-5-chloro-2-methoxybenzoate
|
|
C10H11BrClNO3 |
详情 |
详情
|
(III) |
26534 |
3,5-dimethylpiperidine
|
35794-11-7 |
C7H15N |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(B) Activation of butyric acid derivative (I) with isobutyl chloroformate (II) by means of Et3N in THF, followed by coupling with ethylamine (III) in THF in the presence of Et3N, yields butyramide derivative (IV). Reduction of (IV) by means of (-)-B-chlorodiisopinocampheylborane (Ipc2BCl) in THF, followed by reaction with diethanolamine (A), affords hydroxy derivative (V), whose carbonyl group is removed by means of sodium bis(2-methoxyethoxy)aluminum hydride (Red-Al) in toluene/THF, followed by treatment with H2SO4 to provide compound (VI) .
Separately, the synthesis of intermediate (XIV) is performed as follows: condensation of pentamethylene chlorohydrin (VII) with 3,4-dihydro-2H-pyran (VIII) by means of p-toluenesulfonic acid in Et2O furnishes 5-chloropentyl-2-tetrahydropyranyl ether (IX), which is then subjected to reaction with acetone (X) in THF by means of Mg in the presence of 1,2-dibromoethane (B) to provide tetrahydropyranyl ether (XI). Conversion of hydroxy derivative (XI) into the corresponding fluoro derivative (XII) is performed by reaction with diethylaminosulfur trifluoride (DAST) in CH2Cl2, and posterior reaction of (XII) with pyridinium p-toluenesulfonate in EtOH furnishes 6-fluoro-6-methyl-1-heptanol (XIII). Finally, intermediate (XIV) is obtained by reaction of (XIII) with NBS and PPh3 in benzene.
Condensation of secondary amine (VI) with intermediate (XIV) by means of NaHCO3 in refluxing acetonitrile provides methanesulfonamide (XV), which is finally converted into the target product by formation of the hemifumarate salt by treatment with fumaric acid (XVI) in acetone.
【1】
Hester, J.B.; Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: Synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential. J Med Chem 2001, 44, 7, 1099. |
【2】
Hester, J.B. Jr.; Gibson, J.K. (Pharmacia Corp.); Antiarrhythmic (S)-enantiomers of methanesulfonamides. EP 0802900; JP 1999500418; WO 9621643 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(A) |
24273 |
2-[(2-hydroxyethyl)amino]-1-ethanol
|
111-42-2 |
C4H11NO2 |
详情 | 详情
|
(I) |
14625 |
4-[4-[(methylsulfonyl)amino]phenyl]-4-oxobutyric acid
|
|
C11H13NO5S |
详情 |
详情
|
(II) |
14932 |
isobutyryl chloride; 2-methylpropanoyl chloride
|
79-30-1 |
C4H7ClO |
详情 | 详情
|
(III) |
10928 |
Ethanamine
|
75-04-7 |
C2H7N |
详情 | 详情
|
(IV) |
48114 |
N-ethyl-4-[4-[(methylsulfonyl)amino]phenyl]-4-oxobutanamide
|
|
C13H18N2O4S |
详情 |
详情
|
(V) |
48115 |
(4S)-N-ethyl-4-hydroxy-4-[4-[(methylsulfonyl)amino]phenyl]butanamide
|
|
C13H20N2O4S |
详情 |
详情
|
(VI) |
48116 |
N-[4-[(1S)-4-(ethylamino)-1-hydroxybutyl]phenyl]methanesulfonamide
|
|
C13H22N2O3S |
详情 |
详情
|
(VII) |
48117 |
5-chloro-1-pentanol
|
|
C5H11ClO |
详情 |
详情
|
(VIII) |
13684 |
3,4-Dihydro-2H-pyran;2,3-Dihydro-4H-pyran; 5,6-Dihydro-4H-pyran;Dihydropyran |
110-87-2 |
C5H8O |
详情 | 详情
|
(IX) |
48118 |
2-[(5-chloropentyl)oxy]tetrahydro-2H-pyran; 5-chloropentyl tetrahydro-2H-pyran-2-yl ether
|
|
C10H19ClO2 |
详情 |
详情
|
(X) |
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
(XI) |
48119 |
2-methyl-6-(tetrahydro-2H-pyran-2-yloxy)-2-hexanol
|
|
C12H24O3 |
详情 |
详情
|
(XII) |
48120 |
5-fluoro-5-methylhexyl tetrahydro-2H-pyran-2-yl ether; 2-[(5-fluoro-5-methylhexyl)oxy]tetrahydro-2H-pyran
|
|
C12H23FO2 |
详情 |
详情
|
(XIII) |
48121 |
6-fluoro-6-methyl-1-heptanol
|
|
C8H17FO |
详情 |
详情
|
(XIV) |
48122 |
1-bromo-6-fluoro-6-methylheptane
|
|
C8H16BrF |
详情 |
详情
|
(XV) |
48123 |
N-(4-[(1S)-4-[ethyl(6-fluoro-6-methylheptyl)amino]-1-hydroxybutyl]phenyl)methanesulfonamide
|
|
C21H37FN2O3S |
详情 |
详情
|
(XVI) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(X) The condensation of 3,4-dimethylbenzyl chloride (I) with diethyl malonate (II) by means of sodium ethoxide ethanol gives the diethyl 2-(3,4-dimethylbenzyl)malonate (III), which by treatment with aqueous refluxing NaOH and the with refluxing aqueous sulfuric acid yields 3-(3,4-dimethylphenyl)propionic acid (IV). The reaction of (IV) with refluxing SOCl2 affords the corresponding acyl chloride (V), which is treated with ammonia providing the amide (VI). The reduction of (VI) with LiAlH4 in refluxing THF gives 3-(3,4-dimethylphenyl)propylamine (VII), which by condensation with 2-(4-hydroxy-3-methoxyphenyl)acetic acid (VIII) by heating at 150 C yields the corresponding amide (IX). The alkylation of the phenolic group of (IX) with 1,2-dibromoethane (X) and NaH in refluxing THF affords the 2-bromoethoxy derivative (XI), which by treatment with NaN3 and Bu4NBr in refluxing benzene gives the 2-azidoethoxy derivative (XII). Finally, this compound is reduced with H2 over Pd/C in ethyl acetate to afford the target compound.
【1】
Lee, J.-C.; Lee, K.-S.; Han, M.-S.; Jung, Y.S.; Choi, J.; Park, N.-S.; Ha, D.-C.; Seong, C.-M.; Lim, H.-J.; Choi, S.W.; Synthesis of homovanillic amide derivatives and their analgesic activity. Arch Pharmacal Res 1996, 19, 3, 246.
|
【2】
Lim, H.-J.; Park, N.-S.; Choi, J.-K.; Ha, D.-C.; Kim, H.-S.; Lee, B.-Y.; N-Aralkylated 4-(2-aminoethoxy)phenylacetamide derivatives as potent analgesic and antiinflammatory agents. Korean Journal of Medicinal Chemistry 1991, 1, 1, 36.
|
【3】
Lee, K.S.; Choi, J.K.; Hong, M.S.; Kim, H.S.; Lim, H.J.; Ha, D.C.; Park, N.S. (Korea Research Institute of Chemical Technology); Novel phenylacetamide derivs. and processes for the preparation thereof. EP 0525360; US 5242944 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40283 |
4-(chloromethyl)-1,2-dimethylbenzene
|
102-46-5 |
C9H11Cl |
详情 | 详情
|
(II) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(III) |
40284 |
diethyl 2-(3,4-dimethylbenzyl)malonate
|
|
C16H22O4 |
详情 |
详情
|
(IV) |
40285 |
3-(3,4-dimethylphenyl)propionic acid
|
|
C11H14O2 |
详情 |
详情
|
(V) |
40286 |
3-(3,4-dimethylphenyl)propanoyl chloride
|
|
C11H13ClO |
详情 |
详情
|
(VI) |
40287 |
3-(3,4-dimethylphenyl)propanamide
|
|
C11H15NO |
详情 |
详情
|
(VII) |
40288 |
3-(3,4-dimethylphenyl)-1-propanamine; 3-(3,4-dimethylphenyl)propylamine
|
|
C11H17N |
详情 |
详情
|
(VIII) |
40289 |
4-Hydroxy-3-methoxyphenylacetic acid; Homovanillic acid; 2-(4-hydroxy-3-methoxyphenyl)acetic acid
|
306-08-1 |
C9H10O4 |
详情 | 详情
|
(IX) |
40290 |
N-[3-(3,4-dimethylphenyl)propyl]-2-(4-hydroxy-3-methoxyphenyl)acetamide
|
|
C20H25NO3 |
详情 |
详情
|
(X) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(XI) |
40291 |
2-[4-(2-bromoethoxy)-3-methoxyphenyl]-N-[3-(3,4-dimethylphenyl)propyl]acetamide
|
|
C22H28BrNO3 |
详情 |
详情
|
(XII) |
40292 |
2-[4-(2-azidoethoxy)-3-methoxyphenyl]-N-[3-(3,4-dimethylphenyl)propyl]acetamide
|
|
C22H28N4O3 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(XX) Synthesis of morpholine intermediate (I): Treatment of 4-fluorophenyl acetic acid (X) with trimethylacetyl chloride (XI) and Et3N in Et2O followed by reaction with 4-(S)-benzyl-2-oxazolidinone (XII) in THF and n-BuLi in hexane affords oxazolidinone derivative (XIII). Conversion of (XIII) into azido derivative (XV) is achieved by first treatment of (XIII) in THF with a potassium bis(trimethylsilyl)amide solution in toluene followed by treatment with 2,4,6-triisopropylphenylsulfonyl azide (XIV) in THF. Hydrolysis of azido-oxazolidinone derivative (XV) by means of LiOH in THF/H2O yields azido acetic acid derivative (XVI), which is then hydrogenated over Pd/C in H2O/HOAc to afford (S)-(4-fluorophenyl)glycine (XVII). Treatment of (S)-(4-fluorophenyl)glycine (XVII) with benzaldehyde (XVIII), NaOH and NaBH4 in MeOH yields N-benzyl (S)-(4-fluorophenyl)glycine (XIX), which is then cyclized with 1,2-dibromoethane (XX) in the presence of DIEA in DMF to furnish morpholine intermediate (I).
【1】
Castaner, J.; Silvestre, J.S.; Bayes, M.; Sorbera, L.A.; Aprepitant and L-758298. Drugs Fut 2002, 27, 3, 211.
|
【2】
Dorn, C.P.; Hale, J.J.; Maccoss, M.; Mills, S.G. (Merck & Co., Inc.); Prodrugs of morpholine tachykinin receptor antagonists. EP 0748320; JP 1997509935; US 5691336; WO 9523798 .
|
【3】
Dorn, C.P.; Hale, J.J.; Maccoss, M.; Mills, S.G.; Ladduwahetty, T.; Shah, S.K. (Merck & Co., Inc.); Morpholine and thiomorpholine tachykinin receptor antagonists. EP 0577394; JP 1994172178; US 5719147; WO 9400440; WO 9516679 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18288 |
(3S)-4-benzyl-3-(4-fluorophenyl)-2-morpholinone
|
|
C17H16FNO2 |
详情 |
详情
|
(X) |
18999 |
4-Fluorophenylacetic acid; 2-(4-Fluorophenyl)acetic acid
|
405-50-5 |
C8H7FO2 |
详情 | 详情
|
(XI) |
13597 |
2,2-Dimethylpropanoyl chloride; Pivaloyl chloride
|
3282-30-2 |
C5H9ClO |
详情 | 详情
|
(XII) |
14694 |
(S)-4-Benzyl-2-oxazolidinone; (4S)-4-Benzyl-1,3-oxazolan-2-one; (S)-(-)-4-Benzyl-2-oxazolidinone
|
90719-32-7 |
C10H11NO2 |
详情 | 详情
|
(XIII) |
44186 |
(4S)-4-benzyl-3-[2-(4-fluorophenyl)acetyl]-1,3-oxazolidin-2-one
|
|
C18H16FNO3 |
详情 |
详情
|
(XIV) |
44187 |
2,4,6-triisopropylbenzenesulfonyl azide
|
|
C15H23N3O2S |
详情 |
详情
|
(XV) |
44188 |
(4S)-3-[(2S)-2-azido-2-(4-fluorophenyl)ethanoyl]-4-benzyl-1,3-oxazolidin-2-one
|
|
C18H15FN4O3 |
详情 |
详情
|
(XVI) |
44189 |
(2S)-2-azido-2-(4-fluorophenyl)ethanoic acid
|
|
C8H6FN3O2 |
详情 |
详情
|
(XVII) |
43098 |
(2R)-2-amino-2-(4-fluorophenyl)ethanoic acid
|
7292-73-1 |
C8H8FNO2 |
详情 | 详情
|
(XVIII) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(XIX) |
44190 |
(2S)-2-(benzylamino)-2-(4-fluorophenyl)ethanoic acid
|
|
C15H14FNO2 |
详情 |
详情
|
(XX) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
Alkylation of diphenylacetonitrile (I) with dibromoethane provided bromide (II). This was condensed with 2-methylimidazole (III) in the presence of Et3N in DMF to afford the substituted imidazole (IV). Finally, hydrolysis of the cyano group of (IV) with 70% sulfuric acid produced the target amide.
【1】
Miyachi, H.; et al.; Synthesis and antimuscarinic activity of a series of 4-(1-imidazolyl)-2,2-diphenylbutyramides: Discovery of potent and subtype-selective antimuscarinic agents. Bioorg Med Chem 1999, 7, 6, 1151.
|
【2】
Miyachi, H.; Okazaki, K.; Kiyota, H.; Segawa, M. (Kyorin Pharmaceutical Co., Ltd.); Novel imidazole deriv. and process for producing the same. EP 0733621; US 5932607; US 6103747; WO 9515951 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(I) |
14493 |
alpha-phenylbenzeneacetonitrile; 2,2-diphenylacetonitrile; Diphenylacetonitrile
|
86-29-3 |
C14H11N |
详情 | 详情
|
(II) |
26217 |
4-Bromo-2,2-diphenylbutyronitrile; 4-Bromo-2,2-diphenylbutanenitrile
|
39186-58-8 |
C16H14BrN |
详情 | 详情
|
(III) |
15670 |
2-Methylimidazole; 2-Methyl-1H-imidazole
|
693-98-1 |
C4H6N2 |
详情 | 详情
|
(IV) |
26218 |
4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanenitrile
|
|
C20H19N3 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) The intermediate fluoropyrrolidine (XIV) was obtained as follows: Alkylation of ethyl acetoacetate (I) with 1,2-dibromoethane (II) led to the cyclopropane derivative (III). Bromination of (III) provided bromo ketone (IV), which was condensed with (S)-1-phenylethylamine (V), yielding amino ketone (VI). Acylation of amine (VI) with (diethylfosfonyl)fluoroacetyl chloride (VII) gave amide (VIII). Intramolecular Wadsworth-Emmons condensation of keto phosphonate (VIII) in the presence of potassium tert-butoxide produced the pyrrolinone (IX). Catalytic hydrogenation of the pyrroline double bond of (IX), followed by separation of the resultant diastereomeric mixture, furnished pyrrolidinone (X). After saponification of the ethyl ester group of (X), the resulting acid (XI) was subjected to Curtius rearrangement in the presence of DPPA and t-BuOH, giving rise to carbamate (XII). Lactam (XII) reduction by means of borane in THF afforded pyrrolidine (XIII). The N-phenylethyl group of (XIII) was then removed by hydrogenation over Pd/C to furnish the required intermediate pyrrolidine (XIV) (See scheme no. 27170201a, intermediate (IX)).
【1】
Takahashi, H.; et al.; DQ-113 (D61-1113), a potent fluoroquinolone against multi-drug resistance Gram-positive bacteria: Practical synthesis, and in vitro and in vivo activities. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-550. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
15171 |
ethyl 1-acetylcyclopropanecarboxylate
|
|
C8H12O3 |
详情 |
详情
|
(IV) |
15172 |
ethyl 1-(2-bromoacetyl)cyclopropanecarboxylate
|
|
C8H11BrO3 |
详情 |
详情
|
(V) |
20042 |
(1S)-1-phenyl-1-ethanamine; (1S)-1-phenylethylamine
|
|
C8H11N |
详情 |
详情
|
(VI) |
55739 |
ethyl 1-(2-{[(1S)-1-phenylethyl]amino}acetyl)cyclopropanecarboxylate
|
|
C16H21NO3 |
详情 |
详情
|
(VII) |
55740 |
diethyl 2-chloro-1-fluoro-2-oxoethylphosphonate
|
|
C6H11ClFO4P |
详情 |
详情
|
(VIII) |
55741 |
ethyl 1-(2-{[2-(diethoxyphosphoryl)-2-fluoroacetyl][(1S)-1-phenylethyl]amino}acetyl)cyclopropanecarboxylate
|
|
C22H31FNO7P |
详情 |
详情
|
(IX) |
55742 |
ethyl 1-{4-fluoro-5-oxo-1-[(1S)-1-phenylethyl]-2,5-dihydro-1H-pyrrol-3-yl}cyclopropanecarboxylate
|
|
C18H20FNO3 |
详情 |
详情
|
(X) |
44225 |
ethyl 1-[(3S,4S)-4-fluoro-5-oxo-1-[(1S)-1-phenylethyl]pyrrolidinyl]cyclopropanecarboxylate
|
|
C18H22FNO3 |
详情 |
详情
|
(XI) |
55743 |
1-{(3S,4S)-4-fluoro-5-oxo-1-[(1S)-1-phenylethyl]pyrrolidinyl}cyclopropanecarboxylic acid
|
|
C16H18FNO3 |
详情 |
详情
|
(XII) |
55744 |
tert-butyl 1-{(3R,4S)-4-fluoro-5-oxo-1-[(1S)-1-phenylethyl]pyrrolidinyl}cyclopropylcarbamate
|
|
C20H27FN2O3 |
详情 |
详情
|
(XIII) |
55745 |
tert-butyl 1-{(3R,4S)-4-fluoro-1-[(1S)-1-phenylethyl]pyrrolidinyl}cyclopropylcarbamate
|
|
C20H29FN2O2 |
详情 |
详情
|
(XIV) |
44231 |
tert-butyl 1-[(3R,4S)-4-fluoropyrrolidinyl]cyclopropylcarbamate
|
|
C12H21FN2O2 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(A) The cyclization of (S)-(+)-phenylethylenediamine (I) with CS2 in alkaline water gives (S)-(+)-4-phenyl-2-mercaptoimidazolidine (II), which is then cyclized again with 1,2-dibromoethane (A) in alkaline isopropanol-water.
【1】
Castañer, J.; Hopkins, S.J.; Blancafort, P.; Serradell, M.N.; Levamisole hydrochloride. Drugs Fut 1979, 4, 6, 420.
|
【2】
Raeymaekers, A.H.M.; et al.; Absolute configurations of the optical isomers of the broad spectrum anthelmintic tetramisole. Tetrahedron Lett 1967, 16, 1467-70.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(I) |
39497 |
(1S)-1-phenyl-1,2-ethanediamine; (1S)-2-amino-1-phenylethylamine
|
|
C8H12N2 |
详情 |
详情
|
(II) |
39498 |
(4S)-4-phenyl-4,5-dihydro-1H-imidazole-2-thiol; (4S)-4-phenyl-4,5-dihydro-1H-imidazol-2-ylhydrosulfide
|
|
C9H10N2S |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
In a related procedure, iodination of acetophenone (XI) gave (XII). Subsequent alkylation of (XII) with dibromoethane afforded bromoethyl ether (XIII), which was converted to sulfide (XIV) by condensation with 4-chlorothiophenol (IX). Mannich reaction of (XIV) with paraformaldehyde and dimethylamine hydrochloride produced tertiary amine (XV), which was quaternized to (XVI) with MeI. Elimination in the resulting ammonium salt (XVI) produced vinyl ketone (XVII). Diketone (XIX) was then obtained by condensation with trimethoxybenzaldehyde (XVIII) in the presence of thiazolium salt (IV). Reduction of both ketone groups of (XIX) using NaBH4 yielded diol (XX), which was further cyclized with orthophosphoric acid in refluxing benzene to furnish a diastereomeric mixture of cis and trans diaryltetrahydrofurans (XXI). Iodine displacement in (XXI) with CuCN produced the corresponding diastereomeric mixture of cyanides, from which the target trans isomer was isolated by column chromatography.
【1】
Ram, B.; et al.; (±)-Trans-2-[3-methoxy-4-(4-chlorophenyl thioethoxy)-5-cyanophenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent PAF-receptor antagonist. Tetrahedron 1999, 55, 33, 10163. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(IV) |
27942 |
3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride
|
4568-71-2 |
C13H16ClNOS |
详情 | 详情
|
(IX) |
27947 |
4-chlorobenzenethiol
|
106-54-7 |
C6H5ClS |
详情 | 详情
|
(XI) |
22604 |
1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone |
498-02-2 |
C9H10O3 |
详情 | 详情
|
(XII) |
27949 |
1-(4-hydroxy-3-iodo-5-methoxyphenyl)-1-ethanone
|
|
C9H9IO3 |
详情 |
详情
|
(XIII) |
27950 |
1-[4-(2-bromoethoxy)-3-iodo-5-methoxyphenyl]-1-ethanone
|
|
C11H12BrIO3 |
详情 |
详情
|
(XIV) |
27951 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-1-ethanone
|
|
C17H16ClIO3S |
详情 |
详情
|
(XV) |
27952 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-3-(dimethylamino)-1-propanone
|
|
C20H23ClINO3S |
详情 |
详情
|
(XVI) |
27953 |
3-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-N,N,N-trimethyl-3-oxo-1-propanaminium iodide
|
|
C21H26ClI2NO3S |
详情 |
详情
|
(XVII) |
27954 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-2-propen-1-one
|
|
C18H16ClIO3S |
详情 |
详情
|
(XVIII) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(XIX) |
27955 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,4-butanedione
|
|
C28H28ClIO7S |
详情 |
详情
|
(XX) |
27956 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,4-butanediol
|
|
C28H32ClIO7S |
详情 |
详情
|
(XXI) |
27957 |
2-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran
|
|
C28H30ClIO6S |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(II) Treatment of acetonitrile derivative (I) with dibromoethane (II) in toluene in the presence of NaNH2 affords bromo compound (III), which is then condensed with imidazole derivative (IV) by means of Et3N in DMF to provide compound (V). Hydrolysis of the cyano group of (V) with aqueous H2SO4 yields amide derivative (VI), which is finally subjected to alkyl quaternization by reaction with bromobenzyl bromide (VI) in acetone to furnish the desired product.
【1】
Miyachi, H.; Kiyota, H.; Segawa, M.; Design, synthesis and antimuscarinic activity of some imidazolium derivatives. Bioorg Med Chem Lett 1999, 9, 20, 3003.
|
【2】
Miyachi, H.; Okazaki, K.; Kiyota, H.; Segawa, M. (Kyorin Pharmaceutical Co., Ltd.); Novel imidazole deriv. and process for producing the same. EP 0733621; US 5932607; US 6103747; WO 9515951 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14493 |
alpha-phenylbenzeneacetonitrile; 2,2-diphenylacetonitrile; Diphenylacetonitrile
|
86-29-3 |
C14H11N |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
26217 |
4-Bromo-2,2-diphenylbutyronitrile; 4-Bromo-2,2-diphenylbutanenitrile
|
39186-58-8 |
C16H14BrN |
详情 | 详情
|
(IV) |
15670 |
2-Methylimidazole; 2-Methyl-1H-imidazole
|
693-98-1 |
C4H6N2 |
详情 | 详情
|
(V) |
26218 |
4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanenitrile
|
|
C20H19N3 |
详情 |
详情
|
(VI) |
47152 |
4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide
|
170105-16-5 |
C20H21N3O |
详情 | 详情
|
(VII) |
16109 |
1-bromo-4-(bromomethyl)benzene; 4-Bromobenzyl bromide
|
589-15-1 |
C7H6Br2 |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(II) The sodium salt of triethyl methanetricarboxylate (I) was alkylated with 1,2-dibromoethane (II) to afford bromide (III). Subsequent condensation of 6-(methylamino)-2-chloropurine (IV) with bromide (III) in the presence of K2CO3 gave adduct (V). Mono-decarbethoxylation of tricarboxylate (V) upon treatment with NaOMe produced malonate (VI), which was further reduced to diol (VII) by means of NaBH4 in CH2Cl2-MeOH. Treatment of (VII) with tetrabenzyl pyrophosphate in the presence of LDA gave rise to the bis-phosphate ester (VIII). The benzyl groups of (VIII) were then cleaved employing boron trichloride, and the resulting phosphoric acid was purified through an ion-exchange resin in the presence of ammonium bicarbonate to furnish the title tetraammonium salt.
【1】
Boyer, J.L.; Nandanan, E.; Kim, Y.-C.; Adams, M.; Harden, T.K.; Jang, S.-Y.; Jacobson, K.A.; Gallo-Rodriguez, C.; Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y1 receptor antagonists. J Med Chem 2000, 43, 4, 746.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47051 |
triethyl methanetricarboxylate
|
6279-86-3 |
C10H16O6 |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
11646 |
triethyl 3-bromo-1,1,1-propanetricarboxylate
|
|
C12H19BrO6 |
详情 |
详情
|
(IV) |
47052 |
2-chloro-N-methyl-9H-purin-6-amine; N-(2-chloro-9H-purin-6-yl)-N-methylamine
|
|
C6H6ClN5 |
详情 |
详情
|
(V) |
47053 |
triethyl 3-[2-chloro-6-(methylamino)-9H-purin-9-yl]-1,1,1-propanetricarboxylate
|
|
C18H24ClN5O6 |
详情 |
详情
|
(VI) |
47054 |
diethyl 2-[2-[2-chloro-6-(methylamino)-9H-purin-9-yl]ethyl]malonate
|
|
C15H20ClN5O4 |
详情 |
详情
|
(VII) |
47055 |
2-[2-[2-chloro-6-(methylamino)-9H-purin-9-yl]ethyl]-1,3-propanediol
|
|
C11H16ClN5O2 |
详情 |
详情
|
(VIII) |
47056 |
dibenzyl 2-([[bis(benzyloxy)phosphoryl]oxy]methyl)-4-[2-chloro-6-(methylamino)-9H-purin-9-yl]butyl phosphate
|
|
C39H42ClN5O8P2 |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(A) The starting phenylethylamine (I) is prepared by condensation of N-formyl-5-bromo-3,4-methylenedioxyphenylethylamine (VIII) with N-carbobenzoxy-3-methoxy-4-hydroxyphenylethylamine (IX) through an Ullman condensation catalysed by CuO, followed by elimination of the formyl group with HCl in methanol.
Compound (VIII) is prepared as follows: 3,4-dihydroxy-5-bromobenzaldehyde (X) is methylenated with methylene bromide (A) and CuO in DMF giving 3,4-methylenedioxy-5-bromobenzaldehyde (XI), which is condensed with nitromethane (B) in acetic acid containing ammonium acetate affording 3,4-methylenedioxy-5-bromo-beta-nitrostyrene (XII). The reduction of (XII) under Clemensen conditions yields 3,4-methylenedioxy-5-bromophenylethylamine (XIII), which is finally formylated with formic acid in decalin.
Compound (IX) is prepared as follows: 3-methoxy-4-hydroxy-beta-nitrostyrene (XIV) is treated with ethyl chloroformate (C) in pyridine yielding the corresponding ethoxycarbonyl derivative (XV), which is reduced under Clemensen conditions to 3-methoxy-4-ethoxycarbonyloxyphenylethylamine (XVI). Finally, this compound is treated first with benzyloxycarbonyl chloride and then with aqueous NaHCO3.
【1】
Tomita, M.; et al.; Synthesis of di-cepharanthine. Tetrahedron Lett 1967, 1201-06.
|
【2】
Serradell, M.N.; Blancafort, P.; Mealy, N.; Castañer, J.; Cepharanthine. Drugs Fut 1979, 4, 7, 481.
|
【3】
Kondo, H.; et al.; US 2206407 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(B) |
39563 |
nitromethane
|
75-52-5 |
CH3NO2 |
详情 | 详情
|
(I) |
39554 |
benzyl 4-[[6-(2-aminoethyl)-1,3-benzodioxol-4-yl]oxy]-3-methoxyphenethylcarbamate
|
|
C26H28N2O6 |
详情 |
详情
|
(VIII) |
39566 |
2-(7-bromo-1,3-benzodioxol-5-yl)ethylformamide
|
|
C10H10BrNO3 |
详情 |
详情
|
(IX) |
39570 |
benzyl 3-hydroxy-4-methoxyphenethylcarbamate
|
|
C17H19NO4 |
详情 |
详情
|
(X) |
39561 |
3-bromo-4,5-dihydroxybenzaldehyde
|
16414-34-9 |
C7H5BrO3 |
详情 | 详情
|
(XI) |
39562 |
7-bromo-1,3-benzodioxole-5-carbaldehyde
|
|
C8H5BrO3 |
详情 |
详情
|
(XII) |
39564 |
4-bromo-6-[(E)-2-nitroethenyl]-1,3-benzodioxole
|
|
C9H6BrNO4 |
详情 |
详情
|
(XIII) |
39565 |
2-(7-bromo-1,3-benzodioxol-5-yl)ethylamine; 2-(7-bromo-1,3-benzodioxol-5-yl)-1-ethanamine
|
|
C9H10BrNO2 |
详情 |
详情
|
(XIV) |
39567 |
2-methoxy-5-[(E)-2-nitroethenyl]phenol
|
|
C9H9NO4 |
详情 |
详情
|
(XV) |
39568 |
ethyl 2-methoxy-5-[(E)-2-nitroethenyl]phenyl carbonate
|
|
C12H13NO6 |
详情 |
详情
|
(XVI) |
39569 |
5-(2-aminoethyl)-2-methoxyphenyl ethyl carbonate
|
|
C12H17NO4 |
详情 |
详情
|
(C) |
11229 |
1-[(Chlorocarbonyl)oxy]ethane;ethyl carbonochloridate; Carbonchloridic acid ethyl ester;Ethyl chloroformate;Ethyl chlorocarbonate |
541-41-3 |
C3H5ClO2 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) Alkylation of cyclopentane carboxylic acid ethyl ester (I) by treatment with dibromoethane (II) in the presence of BuLi in THF affords derivative (III), which is then converted into azide (IV) by first hydrolysis of ethyl ester with NaOH in dioxane, followed by reaction with NaN3 in DMF. Coupling of (IV) with protected cysteines (V) and (VI) by means of HBTU yields compound (VII), which is then subjected to simultaneous Trt removal and oxidation by means of iodine in CHCl3/MeOH to provide cystine derivative (VIII). Acid deprotection of (VIII), followed by coupling to protected tyrosine (IX) and final deprotection of the resulting compound, furnishes the desired cyclic cystine compound. Alternatively, (VII) can be first subjected to acid deprotection to allow next coupling with protected tyrosine (IX), furnishing derivative (X), which is finally oxidized with iodine in CHCl3/MeOH and further deprotected to afford the target cyclic cystine derivative.
【1】
Cook, C.; Kaplan, G.; Fry, D.; Tilley, J.W.; Wolitzky, B.; Hanglow, A.; Joshi, P.; Rowan, K.; Schwinge, V.; Fotouhi, N.; The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic. Bioorg Med Chem Lett 2000, 10, 11, 1171. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46208 |
ethyl cyclopentanecarboxylate
|
|
C8H14O2 |
详情 |
详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
46209 |
ethyl 1-(2-bromoethyl)cyclopentanecarboxylate
|
|
C10H17BrO2 |
详情 |
详情
|
(IV) |
46210 |
1-(2-azidoethyl)cyclopentanecarboxylic acid
|
|
C8H13N3O2 |
详情 |
详情
|
(V) |
38971 |
(5R)-5-benzyl-2-pyrrolidinone
|
|
C11H13NO |
详情 |
详情
|
(VI) |
46211 |
tert-butyl (2R)-2-amino-3-(tritylsulfanyl)propanoate
|
|
C26H29NO2S |
详情 |
详情
|
(VII) |
46212 |
tert-butyl (2R)-2-([[1-(2-[[(2R)-2-[(tert-butoxycarbonyl)amino]-3-(tritylsulfanyl)propanoyl]amino]ethyl)cyclopentyl]carbonyl]amino)-3-(tritylsulfanyl)propanoate
|
|
C61H69N3O6S2 |
详情 |
详情
|
(VIII) |
46213 |
tert-butyl (8R,13R)-13-[(tert-butoxycarbonyl)amino]-6,14-dioxo-10,11-dithia-7,15-diazaspiro[4.12]heptadecane-8-carboxylate
|
|
C23H39N3O6S2 |
详情 |
详情
|
(IX) |
25395 |
(2S)-2-[(tert-butoxycarbonyl)amino]-3-(4-hydroxyphenyl)propionic acid
|
3978-80-1 |
C14H19NO5 |
详情 | 详情
|
(X) |
46214 |
tert-butyl (2R)-2-[[(1-[(5R,8S)-8-(4-hydroxybenzyl)-12,12-dimethyl-4,7,10-trioxo-5-[(tritylsulfanyl)methyl]-11-oxa-3,6,9-triazatridec-1-yl]cyclopentyl)carbonyl]amino]-3-(tritylsulfanyl)propanoate
|
|
C70H78N4O8S2 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(VII) The protection of the OH group of 4-hydroxy-3,5-dimethoxybenzaldehyde (I) with benzyl bromide and K2CO3 DMF gives the benzyl ether (II), which is condensed with ethyl 2-azidoacetate (III) by means of NaOMe in methanol to yield the 2-azido acrylic acid derivative (IV). The cyclization of (IV) in refluxing xylene affords the indole carboxylate (V), which is deprotected by hydrogenation with H2 over PtO2 in THF/methanol to provide 6-hydroxy-5,7-dimethoxy-1H-indole-2-carboxylic acid methyl ester (I). The condensation of (VI) with 1,2-dibromoethane (VII) by means of K2CO3 in DMF gives the 2-bromoethoxy derivative (VIII), which is treated with sodium azide in DMF to yield the 2-azidoethoxy compound (IX). The hydrolysis of the ester group of (IX) with NaOH in THF/water affords the carboxylic acid (X), which is esterified with 4-nitrophenol (XI) by means of DCC and DMAP in dichloromethane to provide the activated ester (XII). The condensation of (XII) with the tetracyclic compound (XIII) by means of NaH in DMF gives the adduct (XIV), which is finally reduced at the azido group with H2 over Pd/C in THF/HOAc to yield the target compound.
【1】
Suzawa, T.; et al.; Synthesis of a novel duocarmycin derivative DU-257 and its application to immunoconjugate using poly(ethylene glycol-dipeptidyl linker capable of tumor specific activation. Bioorg Med Chem 2000, 8, 8, 2175.
|
【2】
Saito, H.; Nagamura, S.; Suzawa, T.; Yamasaki, M.; Ohta, S.; Hanai, N. (Kyowa Hakko Kogyo Co., Ltd.); Toxin conjugates. US 6103236; WO 9635451 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49243 |
3,5-Dimethoxy-4-hydroxybenzaldehyde; 4-Hydroxy-3,5-dimethoxybenzaldehyde; Syringaldehyde
|
134-96-3 |
C9H10O4 |
详情 | 详情
|
(II) |
49244 |
4-Benzyloxy-3,5-dimethoxybenzaldehyde
|
|
C16H16O4 |
详情 |
详情
|
(III) |
49245 |
alpha-azido acetic acid methyl ester
|
|
C3H5N3O2 |
详情 |
详情
|
(IV) |
49246 |
methyl (Z)-2-azido-3-[4-(benzyloxy)-3,5-dimethoxyphenyl]-2-propenoate
|
|
C19H19N3O5 |
详情 |
详情
|
(V) |
49247 |
methyl 6-(benzyloxy)-5,7-dimethoxy-1H-indole-2-carboxylate
|
|
C19H19NO5 |
详情 |
详情
|
(VI) |
49248 |
methyl 6-hydroxy-5,7-dimethoxy-1H-indole-2-carboxylate
|
|
C12H13NO5 |
详情 |
详情
|
(VII) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(VIII) |
49249 |
methyl 6-(2-bromoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylate
|
|
C14H16BrNO5 |
详情 |
详情
|
(IX) |
49250 |
methyl 6-(2-azidoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylate
|
|
C14H16N4O5 |
详情 |
详情
|
(X) |
49251 |
6-(2-azidoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylic acid
|
|
C13H14N4O5 |
详情 |
详情
|
(XI) |
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(XII) |
49252 |
4-nitrophenyl 6-(2-azidoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylate
|
|
C19H17N5O7 |
详情 |
详情
|
(XIII) |
38365 |
methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate
|
|
C14H14N2O3 |
详情 |
详情
|
(XIV) |
49253 |
methyl (3bR,4aS)-6-[[6-(2-azidoethoxy)-5,7-dimethoxy-1H-indol-2-yl]carbonyl]-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate
|
|
C27H26N6O7 |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(II) Alkylation of 7-ethyl-10-hydroxycamptothecin (I) with 1,2-dibromoethane (II) under Williamson's ether synthesis conditions furnished the bromoethyl ether (III). Subsequent regioselective nitration of (III) provided the desired 9-nitro compound (IV), which was further reduced to the corresponding amine (V) by using SnCl2 in concentrated HCl. Finally, cyclization of the bromo amine (V) to give the title hexacyclic compound was carried out either in the presence of KI and K2CO3 in refluxing acetone or on standing in a DMSO solution at room temperature.
【1】
Kim, D.-K.; et al.; Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues. J Med Chem 2001, 44, 10, 1594.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10819 |
(4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 7-Ethyl-10-hydroxycamptothecin
|
|
C22H20N2O5 |
详情 |
详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
50975 |
(4S)-9-(2-bromoethoxy)-4,11-diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
|
|
C24H23BrN2O5 |
详情 |
详情
|
(IV) |
50976 |
(4S)-9-(2-bromoethoxy)-4,11-diethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
|
|
C24H22BrN3O7 |
详情 |
详情
|
(V) |
50977 |
(4S)-10-amino-9-(2-bromoethoxy)-4,11-diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
|
|
C24H24BrN3O5 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(II) 4-Iodophenol (I) is alkylated with 1,2-dibromoethane (II) to afford 1-(2-bromoethoxy)-4-iodobenzene (III). Subsequent palladium-catalyzed coupling of aryl iodide (III) with 3-butyn-1-ol (IV) furnishes the phenylbutynol adduct (V), which is further hydrogenated in the presence of Pd/C to the saturated alcohol (VI). Condensation of the alkyl bromide (VI) with (R)-p-chlorobenzhydrylpiperazine (VII) produces the dialkylated piperazine (VIII). Then, Mitsunobu coupling of arylbutanol (VIII) with phenoxycarbonylaminophenoxyformate (IX) leads to the protected hydroxamic acid (X). This is finally treated with methanolic ammonia to provide the title N-hydroxyurea derivative.
【1】
Chatelain, P.; Differding, E.; Cai, X.; Hussoin, S.; Grewal, G.; Young, M.; Lewis, T.; Toy-Palmer, A.; Scannel, R.; Ellis, J.; Lassoie, M.-A. (UCB SA); Cpds. and methods for treatment of asthma, allergy and inflammatory disorders. JP 2002540198; US 6451801; WO 0058295 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22242 |
4-iodophenol
|
540-38-5 |
C6H5IO |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
64422 |
1-(2-bromoethoxy)-4-iodobenzene; 2-bromoethyl 4-iodophenyl ether
|
|
C8H8BrIO |
详情 |
详情
|
(IV) |
32507 |
3-butyn-1-ol
|
927-74-2 |
C4H6O |
详情 | 详情
|
(V) |
64423 |
4-[4-(2-bromoethoxy)phenyl]-3-butyn-1-ol
|
|
C12H13BrO2 |
详情 |
详情
|
(VI) |
64424 |
4-[4-(2-bromoethoxy)phenyl]-1-butanol
|
|
C12H17BrO2 |
详情 |
详情
|
(VII) |
30404 |
1-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazine
|
|
C17H19ClN2 |
详情 |
详情
|
(VIII) |
64425 |
4-[4-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethoxy)phenyl]-1-butanol
|
|
C29H35ClN2O2 |
详情 |
详情
|
(IX) |
19646 |
1-[([[(phenoxycarbonyl)oxy]amino]carbonyl)oxy]benzene
|
|
C14H11NO5 |
详情 |
详情
|
(X) |
64426 |
1-[(R)-(4-chlorophenyl)(phenyl)methyl]-4-{2-[4-(4-{(phenoxycarbonyl)[(phenoxycarbonyl)oxy]amino}butyl)phenoxy]ethyl}piperazine
|
|
C43H44ClN3O6 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(XII) Reductive alkylation of (S)-(4-fluorophenyl)glycine (VI) with benzaldehyde and NaBH4 generated the N-benzyl amino acid (XI). This was cyclized with 1,2-dibromoethane (XII) to yield the morpholinone (XIII). Reduction of the lactone function of (XIII) with L-Selectride at -70 C, followed by acylation of the intermediate lactol (XIV) with 3,5-bis(trifluoromethyl)benzoyl chloride (XV), furnished the aroyloxy morpholine (XVI) as the main isomer. Ester (XVI) was converted to the enol ether (XVII) upon treatment with dimethyltitanocene, generated from titanocene dichloride and methyllithium. Catalytic hydrogenation of the enol ether double bond of (XVII) with simultaneous benzyl group hydrogenolysis generated the desired morpholine (XVIII) along with its diastereoisomer (XIX); these were separated by flash chromatography.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
43098 |
(2R)-2-amino-2-(4-fluorophenyl)ethanoic acid
|
7292-73-1 |
C8H8FNO2 |
详情 | 详情
|
(XI) |
44190 |
(2S)-2-(benzylamino)-2-(4-fluorophenyl)ethanoic acid
|
|
C15H14FNO2 |
详情 |
详情
|
(XII) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(XIII) |
18288 |
(3S)-4-benzyl-3-(4-fluorophenyl)-2-morpholinone
|
|
C17H16FNO2 |
详情 |
详情
|
(XIV) |
18289 |
(2S,3S)-4-benzyl-3-(4-fluorophenyl)-2-morpholinol
|
|
C17H18FNO2 |
详情 |
详情
|
(XV) |
18290 |
3,5-Bis(trifluoromethyl)benzoyl chloride
|
785-56-8 |
C9H3ClF6O |
详情 | 详情
|
(XVI) |
18291 |
(2R,3S)-4-benzyl-3-(4-fluorophenyl)morpholinyl 3,5-bis(trifluoromethyl)benzoate
|
|
C26H20F7NO3 |
详情 |
详情
|
(XVII) |
18292 |
(2R,3S)-4-benzyl-2-([1-[3,5-bis(trifluoromethyl)phenyl]vinyl]oxy)-3-(4-fluorophenyl)morpholine; (2R,3S)-4-benzyl-3-(4-fluorophenyl)morpholinyl 1-[3,5-bis(trifluoromethyl)phenyl]vinyl ether
|
|
C27H22F7NO2 |
详情 |
详情
|
(XVIII) |
18293 |
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl (2R,3S)-3-(4-fluorophenyl)morpholinyl ether; (2R,3S)-2-([(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]oxy)-3-(4-fluorophenyl)morpholine
|
171482-05-6 |
C20H18F7NO2 |
详情 | 详情
|
(XIX) |
53292 |
(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl (2R,3S)-3-(4-fluorophenyl)morpholinyl ether; (2R,3S)-2-({(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}oxy)-3-(4-fluorophenyl)morpholine
|
n/a |
C20H18F7NO2 |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(II) Guaiacol (I) was alkylated by means of boiling dibromoethane (II) to produce the bromoethyl ether (III). From this, the intermediate amine (VI) was prepared by Gabriel synthesis, via condensation with potassium phthalimide (IV) in hot DMF, followed by hydrazinolysis of the resultant N-substituted phthalimide (V).
【1】
Lin, T.-H.; Chen, I.-J.; Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity. EP 1108710; WO 0005209 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
51402 |
2-(2-Bromoethoxy)methoxybenzene; 1-Bromo-2-(2-methoxyphenoxy)ethane
|
4463-59-6 |
C9H11BrO2 |
详情 | 详情
|
(IV) |
27890 |
Potassium phthalimide
|
1074-82-4 |
C8H4KNO2 |
详情 | 详情
|
(V) |
59617 |
2-[2-(2-methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione
|
|
C17H15NO4 |
详情 |
详情
|
(VI) |
31105 |
2-(2-methoxyphenoxy)ethylamine; 2-(2-methoxyphenoxy)-1-ethanamine
|
1836-62-0 |
C9H13NO2 |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(A) Esterification of 5-iodosalicylic acid (I) with methanol and H2SO4 provides the methyl ester (II). Subsequent palladium-catalyzed coupling of (II) with 3-butyn-1-ol (III) yields adduct (IV). Alkylation of the phenolic hydroxyl group of (IV) with 1,2-dibromoethane affords the bromoethyl ether (V). The bromide group of (V) is then displaced with (R)-p-chlorobenzhydryl piperazine (VI) to produce the disubstituted piperazine (VII). Mitsunobu coupling of alcohol (VII) with phenoxycarbonylamino phenoxyformate (VIII) furnishes the protected N-hydroxy carbamate (IX). Finally, ammonolysis of the ester groups of (IX) gives rise to a mixture of the title N-hydroxyurea derivative, along with the analogous methyl ester (X), which can be separated by means of flash chromatography
【1】
Chatelain, P.; Differding, E.; Cai, X.; Hussoin, S.; Grewal, G.; Young, M.; Lewis, T.; Toy-Palmer, A.; Scannel, R.; Ellis, J.; Lassoie, M.-A. (UCB SA); Cpds. and methods for treatment of asthma, allergy and inflammatory disorders. JP 2002540198; US 6451801; WO 0058295 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(I) |
60359 |
2-hydroxy-5-iodobenzoic acid
|
|
C7H5IO3 |
详情 |
详情
|
(II) |
37875 |
methyl 2-hydroxy-5-iodobenzoate
|
|
C8H7IO3 |
详情 |
详情
|
(III) |
32507 |
3-butyn-1-ol
|
927-74-2 |
C4H6O |
详情 | 详情
|
(IV) |
60360 |
methyl 2-hydroxy-5-(4-hydroxy-1-butynyl)benzoate
|
|
C12H12O4 |
详情 |
详情
|
(V) |
60361 |
methyl 2-[(2-bromoethyl)oxy]-5-(4-hydroxy-1-butynyl)benzoate
|
|
C14H15BrO4 |
详情 |
详情
|
(VI) |
30404 |
1-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazine
|
|
C17H19ClN2 |
详情 |
详情
|
(VII) |
60362 |
methyl 2-[(2-{4-[(4-chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethyl)oxy]-5-(4-hydroxy-1-butynyl)benzoate
|
|
C31H33ClN2O4 |
详情 |
详情
|
(VIII) |
19646 |
1-[([[(phenoxycarbonyl)oxy]amino]carbonyl)oxy]benzene
|
|
C14H11NO5 |
详情 |
详情
|
(IX) |
60363 |
methyl 2-[(2-{4-[(4-chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethyl)oxy]-5-[4-([(phenyloxy)carbonyl]{[(phenyloxy)carbonyl]oxy}amino)-1-butynyl]benzoate
|
|
C45H42ClN3O8 |
详情 |
详情
|
(X) |
60364 |
methyl 5-{4-[(aminocarbonyl)(hydroxy)amino]-1-butynyl}-2-[(2-{4-[(4-chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethyl)oxy]benzoate
|
|
C32H35ClN4O5 |
详情 |
详情
|